✦ LIBER ✦

AOSOP3 Combination of bevacizumab and erlotinib in the treatment of patients with advanced hepatocellular carcinoma with sorafenib-refractory disease: Results of a pilot phase II study

✍ Scribed by T. Yau; H. Wong; P. Chan; T.J. Yao; T.T. Cheung; S.T. Fan; R.T. Poon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of bevacizumab and erloti

✍ Thomas Yau, Hilda Wong, Pierre Chan, T. J. Yao, R. Pang, T. T. Cheung, S. T. Fan 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 156 KB

34 POSTER A phase II study of the combin

✍ M. Thomas; M. Lwasaki; K. Higginbotham; R. Lozano; K. Glover; J. Abbruzzese 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 365 KB

A phase I/II trial of capecitabine combi

✍ Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Motoyam 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 248 KB

Phase 2 study of bevacizumab plus erloti

✍ Philip A. Philip; Michelle R. Mahoney; Kyle D. Holen; Donald W. Northfelt; Henry 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 825 KB

Treatment of Advanced Renal Cell Carcino

✍ John D. Hainsworth; David R. Spigel; Jeffrey A. Sosman; Howard A. Burris III; Ci 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 120 KB

A phase I/II study of S-1 with sorafenib

✍ Ooka, Yoshihiko; Chiba, Tetsuhiro; Ogasawara, Sadahisa; Arai, Kuniaki; Suzuki, E 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 166 KB